Intrinsic Value of S&P & Nasdaq Contact Us

aTyr Pharma, Inc. ATYR

NASDAQ Global Market

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.13
+510.1%

aTyr Pharma, Inc. (ATYR) current share price is $0.84. The gold spot price is $4,808.10 per troy ounce. Using the formula: ATYR in gold = $0.84 × 31.1035 ÷ $4,808.10 = 0.0054 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of ATYR when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding ATYR shares over the measured period.

ATYR in US Dollars
Gold in US Dollars
ATYR in Gold (grams per share)

Real Wealth Growth Rate

ATYR
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{ATYR}_{\text{gold}}(t) = \frac{P_{\text{ATYR}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{ATYR}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{ATYR}_{\text{gold}}^{(T)}}{\text{ATYR}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{ATYR}_\text{gold}^{(0)}$ = initial gold-price, $\text{ATYR}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RLMD
RLMD
Relmada Therapeutics, Inc.
$7.19
-2.57%
UNCY
UNCY
Unicycive Therapeutics, Inc.
$6.94
+4.83%
RPTX
RPTX
Repare Therapeutics Inc.
$2.65
+0.00%
CAMP
CAMP
CAMP4 Therapeutics Corporation
$4.52
-2.59%
DTIL
DTIL
Precision BioSciences, Inc.
$7.23
+1.40%
ALXO
ALXO
ALX Oncology Holdings Inc.
$1.62
-7.71%
HYFT
HYFT
MindWalk Holdings Corp.
$1.18
+8.26%
MGX
MGX
Metagenomi, Inc. Common Stock
$1.43
+2.14%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message